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Introduction: Peri-ictal breathing dysfunction was proposed as a potential mechanism
for SUDEP. We examined the incidence and risk factors for both ictal (ICA) and
post-convulsive central apnea (PCCA) and their relationship with potential seizure severity
biomarkers (i. e., post-ictal generalized EEG suppression (PGES) and recurrence.
Methods: Prospective, multi-center seizure monitoring study of autonomic, and
breathing biomarkers of SUDEP in adults with intractable epilepsy and monitored
seizures. Video EEG, thoraco-abdominal excursions, capillary oxygen saturation, and
electrocardiography were analyzed. A subgroup analysis determined the incidences
of recurrent ICA and PCCA in patients with ≥2 recorded seizures. We excluded
status epilepticus and obscured/unavailable video. Central apnea (absence of
thoracic-abdominal breathing movements) was defined as ≥1 missed breath, and ≥5 s.
ICA referred to apnea preceding or occurring along with non-convulsive seizures (NCS)
or apnea before generalized convulsive seizures (GCS).
Results: We analyzed 558 seizures in 218 patients (130 female); 321 seizures were
NCS and 237 were GCS. ICA occurred in 180/487 (36.9%) seizures in 83/192 (43.2%)
patients, all with focal epilepsy. Sleep state was related to presence of ICA [RR 1.33,
CI 95% (1.08–1.64), p = 0.008] whereas extratemporal epilepsy was related to lower
incidence of ICA [RR 0.58, CI 95% (0.37–0.90), p = 0.015]. ICA recurred in 45/60
(75%) patients. PCCA occurred in 41/228 (18%) of GCS in 30/134 (22.4%) patients,
regardless of epilepsy type. Female sex [RR 11.30, CI 95% (4.50–28.34), p < 0.001] and
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ICA duration [RR 1.14 CI 95% (1.05–1.25), p = 0.001] were related to PCCA presence,
whereas absence of PGES was related to absence of PCCA [0.27, CI 95% (0.16–0.47), p
< 0.001]. PCCA duration was longer in males [HR 1.84, CI 95% (1.06–3.19), p= 0.003].
In 9/17 (52.9%) patients, PCCA was recurrent.
Conclusion: ICA incidence is almost twice the incidence of PCCA and is only seen
in focal epilepsies, as opposed to PCCA, suggesting different pathophysiologies. ICA is
likely to be a recurrent semiological phenomenon of cortical seizure discharge, whereas
PCCA may be a reflection of brainstem dysfunction after GCS. Prolonged ICA or PCCA
may, respectively, contribute to SUDEP, as evidenced by two cases we report. Further
prospective cohort studies are needed to validate these hypotheses.
Keywords: apnea, breathing, epilepsy, ictal central apnea (ICA), seizures, sudden unexpected death in epilepsy
(SUDEP), post-convulsive central apnea (PCCA)
INTRODUCTION
Sudden Unexpected Death in Epilepsy (SUDEP) is the
leading cause of premature mortality in patients with intractable
epilepsy (1). The main SUDEP phenotype comprises frequent
generalized convulsive seizures in patients with early onset,
longstanding epilepsy (2, 3). Both cardiac and respiratory
mechanisms likely contribute to SUDEP pathophysiology
(3, 4), although video electroencephalogram monitored (VEEG)
deaths suggest that terminal cardiac arrest is almost always
preceded by central apnea (5). Central, obstructive and mixed
apneas have all been proposed as SUDEP mechanisms, and
may occur during or after seizures (6–9). Whereas, ictal central
apnea (ICA) is common, prolonged ICA with profound oxygen
desaturation may pose SUDEP risk, as may post-convulsive
central apnea (PCCA) (10–14). The latter, when combined with
bradycardia/asystole, comprised the majority of observed deaths
in the MORTEMUS series, and two near-SUDEP instances in
one observational SUDEP risk study (14). Thus, it is evident that
breathing dysfunction plays a major role in SUDEP, although the
exact characteristics of respiratory compromise that contribute
to death are unknown (15). Since central apnea (prolonged ictal
or post-convulsive) seems a viable, agonal mechanism, we set out
to determine incidence, recurrence, and characteristics of peri-
ictal central apnea. We assessed its influence on potential seizure
severity biomarkers, such as hypoxemia extent and post-ictal
generalized electroencephalographic (EEG) suppression (PGES)
in a prospective study of SUDEP risk biomarkers. Further, we
describe two additional cases of near-SUDEP due to prolonged,
exaggerated peri-ictal central apnea.
MATERIAL AND METHODS
Patient Selection
All patients were prospectively recruited participants in the
NINDS Center for SUDEP Research’s Autonomic and Imaging
Biomarkers of SUDEP multi-center project (U01-NS090407),
and its preliminary phase, the Prevention and Risk Identification
of SUDEPMortality (PRISM) Project (P20NS076965). This study
was carried out in accordance with the recommendations of
University Hospitals Case Medical Center Institutions Review
Boards (UHIRB) and University of Iowa, School of Medicine,
Iowa City (IA) Institutions Review Boards. The protocol was
approved by UHIRB and University of Iowa, School of Medicine,
Iowa City (IA) Institutions Review Boards. All subjects gave
written informed consent in accordance with the Declaration of
Helsinki. Informed written consent was obtained for publication
of two clinical cases. Patients with intractable epilepsy (failure
of adequate trials of two or more antiepileptic medications)
(16) aged ≥18 years underwent video-electroencephalography
(VEEG) evaluation in the adult epilepsy monitoring units (EMU)
of participating centers from September 2011 until April 2018.
We included patients with recorded electroencephalographic
seizures with or without clinical correlate, who had complete
polygraphic physiological recordings sufficient for analysis.
Exclusion criteria were status epilepticus (SE), obscured or
unavailable video, and insufficient multimodal physiological
recording quality.
Demographic and clinical data were collected. Semiology
was classified into two types (17). (1) Generalized convulsive
seizures (GCS) which included generalized tonic-clonic seizures,
focal to bilateral tonic-clonic seizures, and focal onset motor
bilateral clonic seizures. (2) Non-convulsive seizures (NCS),
which included seizures with focal onset without evolution
to bilateral tonic-clonic seizures, myoclonic seizures, absence
seizures, and electroencephalographic seizures without clinical
correlate. We determined state (awake or asleep) at seizure onset.
We defined the putative epileptogenic zone based on clinical
history, seizure semiology, neuroimaging, and VEEG.
Data Collection
All patients underwent prolonged surface VEEG monitoring
using the 10–20 International Electrode System. EEG and
electrocardiogram (EKG) were acquired using Nihon Kohden
(Tokyo, Japan), Micromed (Modigliani Veneto, Italy), and
Xltek (Natus) acquisition platforms. Peripheral capillary oxygen
saturation (SpO2) was monitored using pulse oximetry (Nellcor
OxiMax N-600x [Convidien], Masimo Radical-7 [Irvine],
and SenTec Digital Monitoring System [Therwil BL]) and
plethysmography (Ambu [Ballerup, Denmark] Sleepmate and
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Perfect Fit 2 [Dymedix]). Chest wall and abdominal excursions
were recorded using inductance plethysmography (Ambu,
Ballerup, Denmark and Sleepmate or Perfect Fit 2, Dymedix, St
Paul, MN, USA).
Breathing analysis for apnea utilized careful composite
analysis of inductance plethysmography, EEG breathing artifact
and visually inspected thoraco-abdominal excursions 2min
before seizure onset (clinical or electrographic, whichever that
occurred first). Central apnea (cessation of thoraco-abdominal
breathing movements) was defined as ≥1 missed breath without
any other explanation (i.e., speech, movement, or intervention),
with a minimal duration of 5 s. ICA referred to apnea in NCS,
or apnea occurring in the pre-convulsive phase of GCS. PCCA
referred to apnea after GCS; we preferred this term to post-ictal
central apnea since it could occur after convulsions but before
EEG seizure end. Incidences of ICA and PCCA were determined,
as well as their durations. Apnea could not be, and was not
assessed during tonic or clonic movements, because of invariable
artifact presence in breathing channels. A subgroup analysis
identified recurrences of ICA and PCCA (in ≥2 seizures).
Hypoxemia was defined as SpO2 < 95% and where
baseline SpO2 was already <95% a >1% drop was considered
significant. Oxygen desaturations were classified as mild (SpO2
90–94%), moderate (75–89%), and severe (<75%). For SpO2
evaluation, several time points were considered. Firstly, SpO2 was
determined at baseline, 2min pre-ictally as mean SpO2 in a 15 s,
artifact free epoch. For GCS and NCS, the overall desaturation
nadir referred to the lowest SpO2 value registered during and
up to 3min after the seizure. To evaluate respiration in the pre-
convulsive phase of GCS, an additional desaturation nadir was
considered during this phase in patients with ICA.
Presence and duration of PGES (18) after GCSwas determined
by a validated automated EEG suppression detection tool
(19), and supplemented with visual analysis by two epilepsy
neurophysiologists when the tool gave no solution. Presence
and duration of post-ictal EEG burst suppression were also
determined. Combined PGES and burst suppression comprised
EEG “recovery” duration.
Statistical Analysis
Statistical analyses were conducted using SPSS (version 24; IBM
Corp, Armol, NY, USA) and SAS for Windows 9.4 (SAS Institute
Inc., NC, USA). Summary statistics were reported as mean ±
standard deviation (SD; median, range). Relative risk (RR) for
the primary outcome of ICA and PCCA at a seizure level was
assessed by Generalized Estimating Equation (GEE) with same
subject exchangeable correlation. All variables with a p < 0.20 in
a univariate analysis were included in a multivariate Poisson GEE
regression (20). Variables related to ICA and PCCA durations
were determined using Cox Regression with robust sandwich
covariance estimation (21). Lastly, recurrence of ICA and PCCA
for each patient with at least two seizures in this data were
categorized as binary outcomes and patient-level covariates were
included in respective logistic regressions. Corresponding 95%
CIs of risk and hazard ratios were generated from these models.
The significance level for hypothesis testing was set at p < 0.05.
RESULTS
Demographic and Clinical Characteristics
Among 218 patients (130 female), 558 seizures met inclusion
criteria. Four hundred and twenty-six seizures were previously
reported in two different studies (13, 14).
Mean age at study was 40.2 years ± 14.7 (39; 18–77), mean
epilepsy duration was 16.6 years± 13.8 years (1month−58 years)
and mean age at epilepsy onset was 23.5 years ± 17.2 (20; 1
month-69 years). There were 321 NCS (in 128 patients) and
237 GCS (in 137 patients). State was sleep in 239 seizures and
wakefulness in 318 seizures. One seizure arose from post-ictal
coma in a patient with a seizure cluster.
There were 182 patients (493 seizures) with focal epilepsy and
33 patients (60 seizures) with generalized epilepsy. One patient
had both focal and generalized epilepsy (2 seizures). Epilepsy type
was unknown in 2 patients (3 seizures) (Table 1).
PGES could be determined in all but one GCS, where electrode
artifact prevented accurate interpretation. PGES occurred in
165/236 (69.9%) GCS in 106/136 (77.9%) patients. Mean PGES
duration was 38.9 s ± 21.2 (37; 1–169) and mean EEG recovery
duration was 85 s± 107.9 (54; 1–1,091).
Ictal Central Apnea (ICA) Incidence,
Duration, and Recurrence
ICA could not be confidently ascertained in 71 seizures, all GCS,
due to plethysmographic signal acquisition artifact. ICA occurred









Generalized 60 (10.8%) 33 (15.1%)
Focal 493 (88.3%) 182 (83.5%)
Temporal 292 (52.3%) 115 (52.8%)
Frontal 90 (16.1) 33 (15.1%)
Multifocal 45 (8.1%) 15 (6.9%)
Lateralized 36 (6.5%) 11 (5%)
Occipital 11 (2%) 4 (1.8%)
Parietal 12 (2.2%) 2 (0.9%)
Insular 7 (1.3%) 2 (0.9%)
Focal and generalized 2 (0.4%) 1 (0.55)







Focal and generalized 2 1
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FIGURE 1 | Ictal central apnea (ICA) timing with respect to EEG onset (A) and clinical onset (B).
in 180/487 (36.9%) seizures in 83/192 (43.2%) patients: 65/166
(39.2%) in GCS and 115/321 (35.8%) in NCS (p= 0.960).
ICA preceded EEG seizure onset in 85/180 (47.2%) seizures
by 9 s ± 9.5 (7; 1–58). ICA occurred after EEG seizure onset in
74/180 (41.1%) seizures, with a delay of 25.8 s ± 62 (8; 1–436).
ICA coincided with EEG seizure onset in the remaining 21/180
(11.7%) seizures (Figure 1A).
ICA was the sole manifestation in 14/180 (7.8%) seizures. It
coincided with clinical onset in 24/166 (14.5%) seizures, started
before clinical onset in 102/166 (61.4%), preceding it by 16.3
± 12.7 s (12; 1–66 s), and started after clinical onset in 40/180
(24.1%) seizures, with a difference of 26.4 s ± 36 (14.5; 1–195)
(Figures 1B, 2A,B).
Information regarding nadir SpO2 in NCS and the pre-
convulsive phase of GCS was available in 141/180 (78.3%)
seizures with ICA, with a mean value of 87.7%± 9.4 (91; 46–99).
All 180 seizures with ICA were seen in focal epilepsies, and
none in patients with generalized epilepsy. In patients with focal
epilepsies ICA was more frequent in temporal lobe epilepsies
than extratemporal (p= 0.002) but there was no association with
laterality (p= 0.215). ICA incidence did not show any differences
regarding sex (p = 0.171) or epilepsy duration (p = 0.077) but
it was related to older age at study (p = 0.004) and older age at
epilepsy onset (p < 0.001). ICA was more frequent in seizures
arising from sleep than during wakefulness (p= 0.013). ICA was
not related to PGES or PCCA and did not affect PGES, EEG
recovery, hypoxemia or PCCA durations or SpO2 nadir in GCS
(p > 0.050) (Table 2).
After multivariate analysis, sleep state was related to presence
of ICA [RR 1.326, CI95% (1.075–1.637), p = 0.008] whereas
extratemporal epilepsy was related to lower incidence of ICA [RR
0.579, CI 95% (0.373–0.900), p= 0.015].
Mean ICA duration was 20.9 s ± 17.5 (14; 5–97 s) and was
longer in patients with NCS without subsequent GCS than those
with subsequent GCS [HR 2.276; CI 95% (1.565–3.311),
p < 0.001] and in temporal lobe epilepsy compared to
extratemporal [HR 1.753, CI 95% (1.065–2.885), p= 0.027]. ICA
duration did not correlate with awake/sleep state at seizure onset
(p > 0.050). Longer ICA duration was associated with lower
SpO2 nadir during the NCS phase of seizures [HR 1.098, CI 95%
(1.064–1.133), p< 0.001] and longer EEG recovery duration [HR
1.002, CI95% (1.001–1.003), p = 0.003]. ICA duration did not
significantly correlate with hypoxemia duration, PGES duration,
or SpO2 nadir in GCS.
Mean number of seizures per patient was 2.6 ± 1.7
(2; 1–8). In the total sample, 92/218 (42.2%) patients
either had only one seizure, or only one analyzable
seizure for ICA. The remaining 126/218 (57.8%) patients
had recurrent seizures and comment on ICA could be
made. ICA occurred in 60/126 (47.6%) patients, and
recurred in 45/60 (75%) of the patients. No clinical
characteristics (age, age at epilepsy onset, epilepsy
duration, sex, and epileptogenic zone) were related to ICA
recurrence (p > 0.05).
Clinical Case 1-Prolonged ICA and near-SUDEP
A 36 year-old right handed man with intractable right temporal
lobe epilepsy of unknown etiology since the age of nine was
enrolled into the study. His seizure semiology consisted of
psychic aura followed by auditory aura with impaired awareness,
and rare secondarily generalization. The last generalized
convulsion had occurred 4 years before the admission. He had
co-morbid depression. Previous antiepileptic drugs (AEDs) were
carbamazepine, phenytoin, valproic acid and zonisamide. At
admission for presurgical evaluation he was on oxcarbazepine
1,800 mg/day. Physical and neurological examinations were
normal. Brain MRI was normal and the interictal PET
scan showed bilateral mesial temporal hypometabolism, more
pronounced on the right. Interictal recordings showed right
temporal sharp waves (maximum at T8>F8). Retrospective
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FIGURE 2 | Example of ictal central apnea (ICA). Sensitivity 7 µV, High Frequency Filter: 70Hz, Time constant: 0.1 s. (A) Twelve seconds after the electrographic
onset, ICA is noted without any other clinical signs. (B) Continuation of ICA, with a total duration of 14 s, followed by breathing resumption. ABD, abdominal; EEG sz
onset, electrographic seizure onset; EKG, electrocardiogram; ICA, Ictal central apnea; s, seconds; THOR, thoracic.
review of older (non-study) VEEG records revealed a near-
SUDEP incident (not included in the above analysis). The patient
had 4 seizures during that admission. The first one, was a
brief (<10 s duration auditory aura). The second and third
seizures, were brief auras with rapid secondarily generalization,
one arising from wakefulness and the other one arising from
sleep. No comment about presence of ICA could be made
on those seizures due to lack of plethysmography and rapid
secondary generalization. No PCCA was noted in any of the
GCS and regular breathing resumed immediately after clinical
seizure end. These GCS occurred within 12 h of the fourth
and last seizure. This was an apneic seizure with impaired
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TABLE 2 | ICA incidence and seizure characteristics.
Univariate analysis Multivariate analysis
ICA– ICA+ p RR (95% CI) p
Sex 0.171 0.87 (0.64–1.18) 0.383
Male 129 91
Female 178 89
Age at study (y.o) 38.2 ± 14.9 44.5 ± 15.3 0.004 – –
Age at epilepsy onset
(y)
18.7 ± 16.4 28 ± 17.1 <0.001 1.01 (1.00–1.02) 0.222
Epilepsy duration (y) 19.5 ± 14.1 16.6 ± 14.1 0.077 0.98 (0.97–1.00) 0.608
Epilepsy type – – –
Generalized 51 0
Focal 251 180
Epileptogenic zone 0.002 0.58 (0.37–0.90) 0.015
Extratemporal 133 40
Temporal 118 140
Lateralization 0.215 – –
Left 90 94
Right 99 52




GCS 101 65 0.960 – –
NCS 206 115
PGESa 0.308 – –
No 90 12
Yes 70 53
PGES durationa (s) 36.3 ± 15.8 43.3 ± 29.7 0.618 – –
EEG recovery duration
(s)
70.9 ± 61.8 106.2 ± 162.1 0.512 – –
Recovery time to mild
hypoxemiaa (s)
41.8 ± 31.9 48.5 ± 46 0.903 – –
Total hypoxemia
durationa (s)
147.5 ± 70.4 149.9 ± 56.2 0.953 – –
SpO2 nadir
a (%) 59.5 ± 14.4 58.3 ± 13.2 0.576 – –
PCCAa 0.785 – –
No 79 49
Yes 18 14
PCCA durationa (s) 8 ± 3.3 10.4 ± 6.7 0.509 – –
GCS, generalized convulsive seizures; NCS, non-convulsive seizures; PCCA, post-convulsive central apnea; PGES, post-ictal generalized electroencephalographic suppression; SpO2,
peripheral capillary oxygen saturation; y, years y.o, years old.
aAnalyzed only in GCS.
awareness, and respiratory arrest lasting for 285 s, as evidenced
by video analysis and oxygen desaturation. After a period of
several shallow breaths, breathing finally resumed normally 311 s
after seizure onset. Ictal EEG showed rhythmic alpha activity
arising over the right antero-mesial temporal lobe with bilateral
spread. No alteration in heart rhythm was noted apart from
tachycardia. The patient was repositioned, oxygen administered,
and ventilated with a face mask. He later underwent invasive
evaluation, had further seizures without apnea, and a right
temporal lobectomy in 2016 which resulted in seizure freedom
(Engel Class 1, [>2 years]) Video 1.
Post-convulsive Central Apnea (PCCA)
Incidence, Duration, and Recurrence
Presence of PCCA could not be confidently ascertained in
9/237 (3.8%) GCS in 3/137 (2.2%) patients due to movement
artifact. PCCA was present in 41/228 (18%) of GCS in 30/134
(22.4%) patients.
In 24/41 (58.65%) seizures (in 19 patients), PCCA was
observed without EEG seizure. In 14/41 (34.1%) seizures (in 12
patients), PCCA occurred with ongoing EEG seizure activity.
In 3 seizures (in 3 patients) PCCA recurred in the same
seizure, occurring initially with EEG seizure discharges and
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then after 1–2 breaths, recurring without accompanying seizure
discharge(Figures 3A,B). In 13 seizures (in 11 patients), PCCA
immediately followed clinical seizure end. In 25 seizures (in 20
patients), “delayed” PCCA occurred several breaths after clinical
seizure end.
PCCA was more frequent in women than in men (p = 0.004)
and occurred more often in generalized than focal epilepsies
(p = 0.016). In focal epilepsy, it was more frequently seen in
extratemporal than temporal (p = 0.020) patients, but there
was no relationship with lateralization (p = 0.148). PCCA was
unrelated to age at study or epilepsy onset, epilepsy duration and
awake or sleep states (p> 0.050). Whereas, ICA presence was not
related to PCCA occurrence, PCCA was significantly associated
with longer ICA duration (p= 0.001).
Presence of PCCA was not related to PGES duration, and was
not associated with EEG recovery duration and total hypoxemia
duration (p> 0.050). However, PCCAwas associated with longer
SpO2 recovery times to mild hypoxemia (>90%). [RR 1.01,
CI95% (1.003–1.017), p= 0.003] (Table 3).
After multivariate regression analysis, female sex [RR 11.297,
CI 95% (4.50–28.34), p < 0.001] and ICA duration [RR 1.149 CI
95% (1.053–1.254), p = 0.001] were related to PCCA, whereas
absence of PGES was related to absence of PCCA [RR = 0.274,
CI 95% (0.159–0.471), p < 0.001].
Mean PCCA duration was 8.9 s ± 4.9 (5–32). PCCA duration
was longer in males [HR 1.844, CI 95% (1.06–3.19), p =
0.003]. Epilepsy type, awake/sleep state did not influence PCCA
occurrence. PCCA duration did not correlate with age, epilepsy
duration, PGES duration, EEG recovery, hypoxemia duration, or
time to recovery to mild hypoxemia (p > 0.050).
Mean number of GCS per patient was 1.7 ± 1 (1; 1–5). In
patients with GCS, 77/137 (56.2%) had only one GCS and the
remaining 60/137 (47.8%) had two or more GCS. In the group of
patients with repeated GCS, comment on PCCA could be made
on 57/60 (95%) patients. PCCA was seen in 17/57 (29.8%). In
9/17 (52.9%) patients, PCCA was recurrent.
Clinical Case 2-Prolonged PCCA and near-SUDEP
A 15 year-old right handed girl with epilepsy since age 5
years was admitted for evaluation. She was not an enrolled
study patient. Seizures occurred once or twice a month and
lasted up to two with whole body sensory aura (tingling)
followed by oral automatisms with impaired awareness. This
was rarely followed by secondary generalized convulsions lasting
1–2min. On several occasions, paramedics were summoned as
an emergency because of cyanosis and unresponsiveness after
generalized convulsions. On admission she was on lamotrigine
200 mg/day and levetiracetam 3,000 mg/day, having previously
failed multiple other AEDS. She had no epilepsy risk factors
and no family history of epilepsy. Her physical and neurological
examinations were normal. Epilepsy protocol MRI brain scans
were normal on two occasions. Inter-ictal brain FDG-PET
showed focal hypometabolism in the anterior left temporal lobe
tip. Non–invasive VEEG monitoring showed left temporal sharp
waves, maximum at F7/T7/FT9. Four habitual clinical seizures
were recorded without secondarily generalization. EEG onsets
were left hemispheric but not further localizable.
She underwent invasive EEG monitoring for better
localization of the epileptogenic zone. A left subdural grid
(8 × 6) was implanted along with strips covering the left
orbitofrontal, superior temporal, inferior temporal regions,
as well as left anterior-anterior, anterior-middle and anterior-
posterior temporal, left middle temporal, left middle-middle, and
middle-posterior. A left anterior temporal seizure was recorded,
with typical automatisms and impaired awareness, right face
clonic movements, and a secondary generalized tonic clonic
seizure. After clinical seizure end, the patient was immediately
apneic (as evidenced by video analysis, cyanosis, and severe
O2 desaturation) for 126 s, followed by an isolated breath. A
second period of apnea/hypopnea was then seen until regular
breathing pattern resumed a total of 187 s after clinical seizure
end. EEG seizure discharges were seen up to 25 s after clinical
seizure end. Thirty nine seconds after clinical seizure end, there
was concurrent progressive bradycardia followed by 10 s of
asystole. Cardiac rhythm resumed, with a pattern of bradycardia
and normal sinus rhythm, for 75 s, after which EKG signal was
lost, but pulse artifact was evident on EEG. EEG suppression
duration (all invasive electrodes), was ∼254 s. During the
episode, there was repeated tactile nursing intervention. Further,
her head was re-positioned and O2 administered. No active
resuscitation measures were performed. Due to continuing
seizures, the patient underwent responsive neurostimulation
(RNS R© System) and was temporarily seizure free for 3 years,
until recent recurrence of focal seizures at last follow up Video 2.
DISCUSSION
In this study we summarize incidence and risk factors for both
ICA and PCCA. Additionally, we describe two near-SUDEP
instances of prolonged ICA and PCCA, respectively.
ICA incidence in our study (43.2%), on a larger number
of patients, was similar to those previously reported (10, 13).
Consistent with our previous reports, ICA was not observed
in patients with generalized epilepsy, and was more frequent
in patients with temporal rather than extratemporal epilepsy
(13, 14). ICA preceded other clinical signs in the vast majority of
seizures and in almost half of them, also preceded EEG seizure
onset. The observation of ICA being an exclusive feature for
focal epilepsies, and especially in those from the temporal lobe, is
consistent with previous human stimulation studies pointing out
the amygdala, hippocampus, andmesial temporal pole, regardless
of lateralization, as the symptomatogenic zone for ICA (11, 13,
22). The absence of ICA in the GCS of generalized epilepsy is
in large part due to immediate or rapid generalization where
breathing compromisemay be partly or wholly due to generalized
muscle tonicity that includes respiratory musculature, rather
than solely due to unequivocal central apnea. However, we
cannot be sure that these patients truly do not have ICA.
Unlike previous publications (13), where no differences
between awake/sleep states at seizure onset were found, in this
more robustly powered study, ICA occurred more frequently
in seizures arising from sleep. One possible explanation is that
ICA is easier to detect in the sleep state, where acquisition
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FIGURE 3 | Example of post-convulsive central apnea (PCCA). Sensitivity 20 µV, High Frequency Filter: 70Hz, Time constant: 0.1 s. (A). After the end of convulsive
phase, the patient is apneic for 7 s. After the electrographic end, there are 2 noticeable breaths which are followed by another brief apnea. Lastly, regular breathing
resumes. (B) Continuation from (A), regular breathing continues. ABD, abdominal; Clinical sz end, end of clinical seizure. EEG sz end, electrographic seizure end;
EKG, electrocardiogram; PCCA, post-convulsive central apnea; s, seconds; THOR, thoracic.
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TABLE 3 | PCCA incidence and seizure characteristics.
Univariate analysis Multivariate analysis
PCCA – PCCA + p RR (95% CI) p
Sex 0.004 11.29 (4.5–28.34) <0.001
Male 103 10
Female 84 31
Age at study (yo) 37.7 ± 13.7 34.6 ± 14 0.267 – –
Age at epilepsy onset 20.2 ± 17.2 19.5 ± 10.7 0.774 – –
Epilepsy duration (y) 17.4 ± 12.1 14.9 ± 11.9 0.323 – –
Epilepsy type 0.016 – –
Generalized 25 11
Focal 160 27
Epileptogenic zone 0.020 4.48 (1.02–19.59) 0.046
Extratemporal 64 18
Temporal 96 9
Lateralization 0.148 – –
Left 63 14
Right 52 4
State 0.738 – –
Awake 97 20
Asleep 90 20
ICA duration 11.96 ± 5.75 18.6 ± 11.5 0.001 1.14 (1.05–1.25) 0.001
PGESa 0.091 0.27 (0.16–0.47) <0.001
No 60 8
Yes 126 33
PGES durationa (s) 38.7 ± 18.9 39.5 ± 27.8 0.804 – –
EEG recovery durationa (s) 86.4 ± 80 83.5 ± 184.4 0.876 – –
Recovery time to mild hypoxemiaa (s) 36.2 ± 31.3 58.3 ± 42 0.003 – –
Total hypoxemia durationa (s) 144.86 ± 70.3 139.1 ± 40.9 0.301 – –
SpO2 nadir
a 60.76 ± 13.8 58.3 ± 16 0.555 – –
GCS, generalized convulsive seizures; ICA, ictal central apnea; NCS, non-convulsive seizures; PCCA, post-convulsive central apnea; PGES, post-ictal generalized
electroencephalographic suppression; SpO2, peripheral capillary oxygen saturation; y, years; y.o, years old.
aAnalyzed only in GCS.
artifact is less prevalent. However, awake recordings were
not disproportionately excluded because of artifact and such
disparities can be explained by physiological differences in
breathing control during sleep and wakefulness (23). Breathing
is under automatic control through multiple pontomedullary
nuclei, the pre-Bötzinger complex (pre-BötC) comprising the
main rhythm generator (24). Cortical and subcortical structures,
such as thalamus, hypothalamus, amygdalo-hippocampal
complex, cerebellum, and mesencephalic nuclei relay to
pontomedullary respiratory centers and along with peripheral
sensory feedback, modulate breathing output (25). There is
increased evidence that serotoninergic neurons lying in the
midline raphe nuclei play an active role in both arousal and
chemoreception (26, 27). These neurons tonically excitate
multiple components of the brainstem respiratory network,
with interconnections with the pre-BötC, and also act as central
chemosensors, detecting changes in tissue CO2/H
+ modulating
the aforementioned tonic excitatory drive to adjust ventilation
accordingly (28). Mice with genetically deleted medullary
serotoninergic neurons lack any arousal response to inhalation
of CO2 but have normal arousal responses to other stimuli such
as hypoxia, sound and air puffs (26). Moreover, the activity
of medullary raphe serotoninergic neurons is highest during
wakefulness and absent during REM sleep (28). Most SUDEP
cases occur at night, and in the MORTEMUS study this was
true in the majority of monitored cases (5) animal studies reveal
brainstem serotoninergic dysfunction during and after seizures,
with decreased firing of the medullary raphe neurons during
the ictal and post-ictal periods (29). Therefore, in the setting of
a potentially dysfunctional serotoninergic network in epileptic
patients, sleep would constitute a vulnerable period for breathing
disturbances (30).
The near-SUDEP case with prolonged ICA, in whom
breathing resumed after seizure end raises a number of
interesting issues. First, it seems possible that unobserved
and in the absence of active intervention, the outcome could
have been fatal. This supports the contention that prolonged
ICA is dangerous and potentially lethal. Second, the near-fatal
seizure episode may be more akin to focal status epilepticus,
and supports the view that the latter cannot be excluded in
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at-home, unobserved deaths that are usually labeled SUDEP
(31). Revisiting SUDEP definition (which mandates exclusion
of status epilepticus) may be necessary. The episode mimics
a sheep model of status epilepticus and apneic death (32).
Third, seizure termination and resumption of breathing with
seizure end, suggest that ICA is driven by seizure discharge
(likely in the mesial temporal structures), rather than other
mechanisms (13). Finally, why the majority of ICA instance
are self-terminating and some become prolonged, is unresolved,
but may reflect the consequences of damage caused by early
onset, long-standing epilepsy, and frequent GCS to key breathing
control sites (amygdala, hippocampus, dorsal thalamus, anterior
cingulate, ventrolateral medulla etc.) (33–35), rendering greater
susceptibility to exaggerated apneic responses.
PCCA incidence (22.4%) was almost half of ICA incidence,
more frequently observed in female subjects (although more
likely to be longer in male patients), and commoner in
those with longer ICA duration. In contrast to ICA, PCCA
was observed in both patients with focal, and generalized
epilepsy. These differences suggest differing pathophysiologies
(14). Whereas, ICA appears to be a semiological phenomenon
most often resulting from seizure activity in the amygdalo-
hippocampal complex, PCCA most likely results from seizure
spread to the brainstem during GCS, regardless of epileptogenic
zone (36). Breathing cessation may be derived either from
active depolarization and activation of crucial breathing centers
that generate apneic responses, such as the periaqueductal
gray (37, 38), or disruption of the normal functioning of
rhythm-generating neurons and its intricate network, leading to
breathing cessation (39). This is consistent with animal models
of SUDEP showing post-ictal depolarization in dorsal medulla
(40), in which apnea and PGES precede cardiac arrest, and
resemble the clinical phenotype of monitored SUDEP patients
in the MORTEMUS study (5). Human neuroimaging and
neuropathological studies have shown damage in key brainstem
structures that modulate breathing, such as the medullary raphe
and ventrolateral medulla, in SUDEP and high SUDEP-risk
patients (33, 41, 42).
In our study, ICA duration conferred higher risk for PCCA
and was related to lower SpO2 nadirs in the pre-convulsive
phase. This may indicate greater hypoxemia induced brainstem
compromise, leading to PCCA. Seizure induced focal brainstem
hypoxia, due to vasospasm, has been described in animal models
and posited as a potential mechanism for SUDEP (43–45).
Moreover, we found that the presence of PCCA was related
to longer hypoxemia recovery times (SpO2 > 90%). Although
causality could not be established, longer hypoxemia recovery
times may be a consequence of PCCA. However, PCCA duration
itself, was not related to hypoxemia severity or duration. PCCA
durations were typically short, and hypoxemia severity may
be more related to GCS severity, although PCCA impact on
hypoxemia may become independently important in instances of
prolonged PCCA.
Although PCCA occurred preferentially in women, its
duration was longer in men, consistent with the SUDEP
phenotype (2). Sex differences in breathing function and the
protective role of estrogens in respiratory diseases may explain
these findings (46–48), since differences in epilepsy phenotype do
not explain these differences. As with ICA, duration rather than
presence, may primarily influence SUDEP risk in PCCA.
PGES is a frequent finding in GCS, particularly in those arising
from sleep and is related to the symmetric tonic phase, postictal
immobility, lack of early oxygen administration, duration of
oxygen desaturation and lower SpO2 nadir values (49–51).
PGES has been postulated as a SUDEP biomarker, especially if
prolonged (>50 s) (18). Its relationship with ICA or PCCA has
not been established, except indirectly through O2 desaturation
findings (50). In our study, PCCA was proportionally seen more
frequently in seizures with PGES than in seizures without. The
pathogenesis of PGES is not well-determined. Cortical neuronal
exhaustion or a disruption of ascending inputs after a GCS,
or a combination of both, are viable hypotheses. Disruption of
ascending pathways such as from the reticular activating system
may conceivably prolong the comatose post-ictal state, as well
as modulate cortical neuronal activity, and thus, impair the
protective behavioral effect of arousal to overcome PCCA (52).
ICA recurred in 75% of the cases, whereas PCCA recurred
in 52.9%. This may further reinforce that ICA is a semiological,
and therefore recurrent, phenomenon. However, PCCA seems
only slightly less frequent, and may also be semiological
rather than probabilistic, although our two case reports
suggest that prolonged instances of either, are what potentially
determine mortality risk. PCCA instances combined with
bradycardia/asystole may be particularly dangerous. Our second
clinical case of prolonged PCCA accompanied by asystole,
resembles the clinical phenotype described in the MORTEMUS
study and in a recent analysis of this cohort in a smaller number
of patients (14). Invasive monitoring did not show ongoing
seizure activity that was concurrent with apnea, reinforcing once
again, the different pathophysiologies of ICA, and PCCA, with
higher likelihood of involvement of subcortical structures, such
as the brainstem, in PCCA (53, 54).
Our study has several limitations. First, it is an observational
study in a select group of patients (i.e., primarily treatment
resistant epilepsy) and does not necessarily reflect seizure
phenomenology or SUDEP risk in a treatment responsive
population. Detection of ICA was heavily dependent on extent
of acquisition artifact, and hence we may have underestimated
incidence. Alternatively, postictal immobility after GCS allowed
PCCA identification in the majority of cases. Breathing analysis
through polygraphic study was limited to thoraco-abdominal
movement and pulse oximetry. Thus, additional information on
the presence of mixed central/obstructive apneas, is unavailable.
Our apnea definition differs from previous literature, which
is based on the 10 s sleep-study criterion, and therefore, ICA
and PCCA incidence may be overestimated in our study.
However, based on our brain stimulation experiments on
breathing modulation, where brief stimulation periods result in
immediate and brief (<10 s) apneas, we believe our definition
is both accurate and sensitive (12, 22). Our conclusions are
based on a relatively small group of number seizures in the
primary generalized epilepsy group compared to patients with
focal epilepsy. Lastly, our study was based on surface EEG
and persistence of intracranial seizure in deep, apnea causing
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structures (12) cannot be completely excluded in patients with
PCCA. However, Case 2 above, along with a previous case
reported in literature, suggest that apnea in epileptic patients can
occur in the absence of electrographic seizure (53).
CONCLUSIONS
Peri-ictal central apnea takes two main forms, as ICA or PCCA.
ICA incidence is almost twice PCCA incidence and is only seen in
focal epilepsies, suggesting different pathophysiologies. Both ICA
and PCCA may be recurrent, but prolonged instances leading
to SUDEP and near-SUDEP may be probabilistic instances.
Prolonged ICA is related to presence of PCCA, possibly due
to greater effect of ICA-induced hypoxemia on brainstem
function. Absence of PCCA is associated with absence of
PGES, suggesting that PCCA presence directly correlates with
GCS severity. Alternatively, brainstem structures responsible for
arousal and breathing may obviate PGES occurrence. Apnea
preceding both EEG as well as clinical seizure onset in a
substantial number of patients suggests that plethysmographic
respiratory monitoring in regular clinical practice may have
seizure detection value. Moreover, suchmonitoringmay facilitate
detection of prolonged ICA and PCCA, thus allowing SUDEP
risk quantification although further evidence is required to
confirm this. Both prolonged ICA and PCCA may contribute to
SUDEP. Further prospective cohort studies are needed to validate
these hypotheses.
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